Elevated Levels of Estrogen Suppress Hepcidin Synthesis and Enhance Serum Iron Availability in Premenopausal Women

Abstract

Clinical and experimental observations have long suggested that elevated levels of estrogen associate with increased serum iron availability. Additionally, recent work has shown that estrogen can downregulate hepcidin synthesis in vitro. This study aims at assessing whether the ability of estrogen to downregulate hepcidin synthesis translates into changes in serum iron status. Hepcidin synthesis was evaluated in MCF-7, Hep-G2 and SKOV-3 cells treated with increasing concentrations of estrogen and cultured for up to 24 h post treatment. The correlation between levels of serum estrogen, hepcidin and iron was assessed using serum samples collected from 153 premenopausal women at random and samples collected from 6 women at days 1, 5, 10, 16, 21 and 28 of the monthly cycle. Estrogen-treated MCF-7 cells showed a significant reduction in hepcidin synthesis, especially at 20 nM/24 h E2 treatment. Hepcidin synthesis was also significantly reduced in Hep-G2 and SKOV-3 cells at 20 nM/24 h E2 treatment. In serum samples collected at random, estrogen (P=0.022; R=−0.213) and iron (P=0.028; R=−0.316) correlated negatively with hepcidin and positively with each other (P=0.033; R=0.319). An overall similar pattern was also observed in monthly cycle-timed samples. These findings suggest that elevated levels of estrogen reduce hepcidin synthesis as means of enhancing serum iron content in menstruating women.

Key words

Estrogen - hepcidin - serum iron - premenopausal women

• References

• 1 Nemeth E, Tuttle MS, Powelson J. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 2004; 306: 2090-2093
• 2 De Domenico I, Lo E, Ward DM. et al. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. Proc Natl Acad Sci 2009; 106: 3800-3805
• 3 De Domenico I, Ward DM, Langelier C. et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 2007; 8: 2569-2578
• 4 Peyssonnaux C, Zinkernagel AS, Schuepbach RA. et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Inves 2007; 117: 1926-1932
• 5 Tanno T, Bhanu NV, Oneal PA. et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007; 13: 1096-1011
• 6 Nemeth E, Rivera S, Gabayan V. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-1276
• 7 Harrison-Findik DD. Gender-related variations in iron metabolism and liver diseases. World J Hepatol 2010; 2: 302-310
• 8 Mattace Raso G, Irace C, Esposito E. et al. Ovariectomy and estrogen treatment modulate iron metabolism in rat adipose tissue. Biochem Pharmacol 2009; 78: 1001-1007
• 9 Campesi I, Sanna M, Zinellu A. et al. Oral contraceptives modify DNA methylation and monocyte-derived macrophage function. Biol Sex Differ 2012; 3: 4
• 10 Ulas M, Cay M. Effects of 17β-estradiol and vitamin E treatments on blood trace element and antioxidant enzyme levels in ovariectomized rats. Biol Trace Elem Res 2011; 139: 347-355
• 11 Stuckey R, Aldridge T, Lim FL. et al. Induction of iron homeostasis genes during estrogen-induced uterine growth and differentiation. Mol Cell Endocrinol 2006; 253: 22-29
• 12 Hua K, Din J, Cao Q. et al. Estrogen and progestin regulate HIF-1 alpha expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway. Oncol Rep 2009; 21: 893-898
• 13 Yang Q, Jian J, Katz S. et al. 17β-estradiol inhibits iron hormone hepcidin though an estrogen responsive element half-site. Endocrinology 2012; 153: 3170-3178
• 14 Hou Y, Zhang S, Wang L. et al. Estrogen regulates iron homeostasis though governing hepatic hepcidin expression via an estrogen response element. Gene 2012; 511: 398-403
• 15 Kantner I, Nubbemeyer R, Schkoldow J. et al. Estradiol release kinetics determine tissue response in ovariectomized rats. Endocrinol 2012; 153: 1725-1733
• 16 Shafarin J, Bajbouj K, El-Serafy A. et al. Estrogen-Dependent Downregulation of Hepcidin Synthesis Induces Intracellular Iron Efflux in Cancer Cells In Vitro. Biol Med (Aligarh) 2016; 8: 7 doi:10.4172/0974-8369.1000356
• 17 Lehtihet M, Bonde Y, Beckman L. et al. Circulating Hepcidin-25 Is Reduced by Endogenous Estrogen in Humans. PLoS ONE 2016; 11: e0148802
• 18 Qian Y, Yin C, Chen Y. et al. Estrogen contributes to regulating iron metabolism though governing ferroportin signaling via an estrogen response element. Cell Signal 2015; 27: 934-942
• 19 Ikeda Y, Tajima S, Izawa-Ishizawa Y. et al. Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes. PLoS ONE 2012; 7: e40465 doi:10.1371/journal.pone.0040465
• 20 Guo W, Bachman E, Li M. et al. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell 2013; 12: 280-291
• 21 Latour C, Kautz L, Besson-Fournier C. et al. Testosterone perturbs systemic iron balance though activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Hepatology 2014; 59: 683-694
• 22 Peter F, Wang S. Serum Iron and Total Iron-Binding Capacity Compared with Serum Ferritin in Assessment of Iron Deficiency. Clin Chem 1981; 27: 276-279
• 23 Wish JB. Assessing Iron Status: Beyond Serum Ferritin and Transferrin Saturation. Clin J Am Soc Nephol 2006; 1 S4/S8 DOI: 10.2215/CJN.01490506.
• 24 Tai P, Wang J, Jin H. et al. Induction of regulatory T cells by physiologic levels of estrogen. J Cell Physiol 2008; 214: 456-464
• 25 Marx J. Iron and infection: competition between host and microbes for a precious element. Best Pract Res Clin Haematol 2002; 15: 411-426
• 26 Ganz T. Hepcidin-a peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol 2006; 306: 183-198
• 27 Mencacci A, Cenci E, Boelaert JR. et al. Iron Overload Alters Innate and T Helper Cell Responses to Candida albicans in mice. J Infect Dis 1997; 175: 1467-1476
• 28 Krausse-Opatz B, Wittkop U, Gutzki FM. et.al. Free iron ions decrease indoleamine 2,3-dioxygenase expression and reduce IFN gamma-induced inhibition of Chlamydia trachomatis infection. Microb Pathog 2009; 46: 289-297
• 29 Hamad M, Awadallah S. Estrogen-dependent changes in serum iron levels as a translator of the adverse effects of estrogen during infection: A conceptual framework. Med Hypotheses 2013; 81: 1130-1134
• 30 Ibrahim AS, Spellberg B, Edwards J. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis 2008; 21: 620-625
• 31 Hamad M, Bajbouj K. The re-emerging role of iron in infection and immunity. Integrative Mol Med 2016; 3: 807-810
• 32 Maximov PY, Lewis-Wambi JS, Jordan VC. The paradox of oestradiol-induced breast cancer cell growth and apoptosis. Curr Signal Transduct Ther 2009; 4: 88-102
• 33 Fan P, Griffith OL, Agboke FA. et al. c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells. Cancer Res 2013; 73: 4510-4520
• 34 Pinnix ZK, Miller LD, Wang W. et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci Transl Med 2010; 2: 43-56
• 35 Manz DH, Blanchette NL, Paul BT. et al. Iron and cancer: Recent insights. Ann N Y Acad Sci 2016; 1368: 149-161 doi:10.1111/nyas.13008
• 36 Jinlong Jian J, Pelle E, Huan X. Iron and Menopause: Does Increased Iron Affect the Health of Postmenopausal Women?. Antioxid & Redox Signal 2009; 11: 2939-2943